肾母细胞瘤患儿外周血调节性T细胞和自然杀伤T细胞的表达研究

陈京; 林涛

doi:10.7499/j.issn.1008-8830.2016.12.005

PDF(2192 KB)

HTML

中国当代儿科杂志 ›› 2016, Vol. 18 ›› Issue (12) : 1222-1226. DOI: 10.7499/j.issn.1008-8830.2016.12.005

论著·临床研究

肾母细胞瘤患儿外周血调节性T细胞和自然杀伤T细胞的表达研究

陈京, 林涛

作者信息 +

Expression of regulatory T cells and natural killer T cells in peripheral blood of children with Wilms tumor

CHEN Jing, LIN Tao

Author information +

文章历史 +

摘要

目的研究肾母细胞瘤患儿外周血CD4⁺CD25⁺CD127^low 调节性T细胞（Treg）和CD3⁺CD16⁺CD56⁺自然杀伤T细胞（NKT）的表达变化，初步探讨发生改变的原因及其临床意义。方法选取2015年11月至2016年7月就诊的21例肾母细胞瘤患儿作为病例组，21例于本院体检的同年龄段健康儿童为健康对照组，采用流式细胞术检测两组儿童外周血中 CD4⁺CD25⁺CD127^low T细胞占CD4⁺T细胞百分比和CD3⁺CD16⁺CD56⁺T细胞占CD3⁺T细胞百分比，分别代表Treg水平和NKT水平。结果病例组肾母细胞瘤患儿外周血Treg水平低于健康对照组（P < 0.05）；病例组肾母细胞瘤患儿外周血NKT水平高于健康对照组（P < 0.05）。结论 Treg和NKT水平变化与肾母细胞瘤的发生与发展有关，Treg和NKT水平可能是反映肾母细胞瘤患儿免疫功能状态的较好指标。

Abstract

Objective To study the changes and clinical significance of CD4⁺CD25⁺CD127^low regulatory T cells (Treg) and CD3⁺CD16⁺CD56⁺ natural killer T cells (NKT) in peripheral blood of children with Wilms tumor. Methods Twenty-one children with Wilms tumor were enrolled as the case group, and twenty-one healthy children for physical examinations were enrolled as the control group. Flow cytometry was used to detect the levels of CD4⁺CD25⁺CD127^low T cells and CD3⁺CD16⁺CD56⁺ T cells in peripheral blood of two groups. Results The level of Treg cells in peripheral blood of the case group was significantly lower than in the control group (P < 0.05). The level of NKT cells in peripheral blood of the case group was significantly higher than in the control group (P < 0.05). Conclusions Treg cells and NKT cells play important roles in the occurrence and development of Wilms tumor. Treg cells and NKT cells may be useful indexes for evaluating immunological function in children with Wilms tumor.

导出引用

陈京, 林涛. 肾母细胞瘤患儿外周血调节性T细胞和自然杀伤T细胞的表达研究[J]. 中国当代儿科杂志. 2016, 18(12): 1222-1226 https://doi.org/10.7499/j.issn.1008-8830.2016.12.005

CHEN Jing, LIN Tao. Expression of regulatory T cells and natural killer T cells in peripheral blood of children with Wilms tumor[J]. Chinese Journal of Contemporary Pediatrics. 2016, 18(12): 1222-1226 https://doi.org/10.7499/j.issn.1008-8830.2016.12.005

参考文献

[1] Pastore G, Znaor A, Spreafico F, et al. Malignant renal tumours incidence and survival in European children (1978-1997):report from the Automated Childhood Cancer Information System project[J]. Eur J Cancer, 2006, 42(13):2103-2114.
[2] Lin YC, Mahalingam J, Chiang JM, et al. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer[J]. Int J Cancer, 2013, 132(6):1341-1350.
[3] Bendelac A, Savage PB, Teyton L. The biology of NKT cells[J]. Annu Rev Immunol, 2007, 25:297-336.
[4] Rijavec M, Volarevic S, Osolnik K, et al. Natural killer T cells in pulmonary disorders[J]. Respir Med, 2011, 105 Suppl 1:S20-S25.
[5] Sakaguchi S, Miyara M, Costantino CM, et al. FOXP3+ regulatory T cells in the human immune system[J]. Nat Rev Immunol, 2010, 10(7):490-500.
[6] Allan SE, Passerini L, Bacchetta R, et al. The role of 2 FOXP3 isoforms in the generation of human CD4⁺ Tregs[J]. J Clin Invest, 2005, 115(11):3276-3284.
[7] Hartigan-O'Connor DJ, Poon C, Sinclair E, et al. Human CD4⁺ regulatory T cells express lower levels of the IL-7 receptor alpha chain(CD127), allowing consistent identification and sorting of live cells[J]. J Immunol Methods, 2007, 319(1-2):41-52.
[8] Joshi SK, Lang ML. Fine tuning a well-oiled machine:Influence of NK1.1 and NKG2D on NKT cell development and function[J]. Int Immunopharmacol, 2013, 17(2):260-266.
[9] Das R, Tripathy A. Increased expressions of NKp44, NKp46 on NK/NKT-like cells are associated with impaired cytolytic function in self-limiting hepatitis E infection[J]. Med Microbiol Immunol, 2014, 203(5):303-314.
[10] Gibson SE, Swerdlow SH, Felgar RE. Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features[J]. Hum Pathol, 2011, 42(5):679-687.
[11] Hus I, Staroslawska E, Bojarska-junak A, et al. CD3⁺/CD16⁺CD56⁺ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma[J]. Folia Histochem Cytobiol, 2011, 49(1):183-187.
[12] Schreiber TH, Wolf D, Bodero M, et al. Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination[J]. Oncoimmunology, 2012, 1(5):642-648.
[13] Reduta T, Stasiak-Barmuta A, Laudańska H. CD4⁺CD25⁺ and CD4⁺CD25^high regulatory T cells in disseminated and localized forms of allergic contact dermatitis:relation to specific cytokines[J]. Folia Histochem Cytobiol, 2011, 49(2):255-262.
[14] Exley MA, Lynch L, Varghese B, et al. Developing understanding of the roles of CD1d-restricted T cell subsets in cancer:reversing tumor-induced defects[J]. Clinical Immunol, 2011, 140(2):184-195.
[15] Obata F, Subrahmanyam PB, Vozenilek AE, et al. Natural killer T (NKT) cells accelerate Shiga toxin type 2(Stx2) pathology in mice[J]. Front Microbiol, 2014, 6:262.
[16] Tan JQ, Xiao W, Wang L, et al. Type I natural killer T cells:naturally born for fighting[J]. Acta Pharmacol Sin, 2010, 31(9):1123-1132.
[17] Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells:an innate activation scheme linked to diverse effector functions[J]. Nat Rev Immunol, 2013, 13(2):101-117.
[18] 杨德娟, 韩波. IL-21及其受体在自身免疫性疾病中的作用[J]. 中国当代儿科杂志, 2016, 18(5):466-471.
[19] 王晓梦, 于津浦, 李慧, 等. IL-2+IL-15组合培养方案对乳腺癌患者外周血中NK细胞体外扩增的效果[J]. 中国肿瘤生物治疗杂志, 2013, 20(6):654-660.
[20] Nguyen KD, Vanichsarn C, Nadeau KC. Increased cytotoxicity of CD4⁺ invariant NKT cells against CD4⁺CD25^hiCD127^lo- regulatory T cells in allergic asthma[J]. Eur J Immunol, 2008, 38(7):2034-2045.
[21] Terabe M, Berzofsky JA. The immunoregulatory role of type I and type II NKT cells in cancer and other diseases[J]. Cancer Immunol Immunother, 2014, 63(3):199-213.